SMALL CELL LUNG CANCER (SCLC )
Clinical trials for SMALL CELL LUNG CANCER (SCLC ) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC ) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to control aggressive lung cancer
Disease control OngoingThis study is testing different dosing schedules of an investigational drug called tarlatamab for people with advanced small cell lung cancer that has progressed after initial chemotherapy. The main goal is to see how well the drug shrinks tumors and controls the cancer. Research…
Matched conditions: SMALL CELL LUNG CANCER (SCLC )
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major cancer trial tests new hope for patients Who've run out of options
Disease control OngoingThis study tested pembrolizumab, an immunotherapy drug, in people with advanced solid tumors who had already tried standard treatments that stopped working. Researchers enrolled 1,609 participants with various cancers including anal, cervical, lung, and thyroid cancers to see how…
Matched conditions: SMALL CELL LUNG CANCER (SCLC )
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New hope for Tough-to-Treat lung cancer: major trial tests promising drug
Disease control OngoingThis study is testing whether a new drug called tarlatamab helps people with small cell lung cancer live longer and feel better after their cancer has returned following initial chemotherapy. It compares tarlatamab directly against the current standard treatments. The main goal i…
Matched conditions: SMALL CELL LUNG CANCER (SCLC )
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Muscle strength could predict lung cancer treatment success
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 160 lung cancer patients to understand how changes in muscle mass, strength, and function affect their ability to complete treatment, quality of life, and survival. Researchers will measure these factors during routine hospital visits without changing standard …
Matched conditions: SMALL CELL LUNG CANCER (SCLC )
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC